Melanoma
News and reporting on melanoma.
Immunocore Outlines Strategic Priorities on Kimmtrak and TCR Therapy Pipeline
The firm is expanding its melanoma portfolio while launching new trials of T-cell receptor therapies in oncology, infectious disease, and autoimmune disease.
UK's NICE Reverses Course on Immunocore's Kimmtrak for Advanced Uveal Melanoma
In recommending Kimmtrak, NICE factored in a new commercial agreement with the sponsor and changed its 2023 negative opinion.
Merck, Moderna Vax Trial Starts Enrolling Lung Cancer Patients at McGill University Health Center
The trials are evaluating an individualized neoantigen vaccine with Keytruda as an adjuvant therapy for non-small cell lung cancer.
Several new studies appear to confirm the test's potential to prevent overtreatment of melanoma patients while identifying those at high risk.
Merck, Moderna Launch Phase III Trial of Adjuvant V940 in NSCLC After Neoadjuvant Keytruda, Chemo
The partners are also studying their personalized vaccine with Keytruda as an adjuvant NSCLC treatment for those who haven't gotten neoadjuvant therapy.
Oct 25, 2024
Alpha-9 Oncology Raises $175M in Series C Financing
Oct 11, 2024
Immatics Prices $150M Stock Offering
Oct 11, 2024
Oct 10, 2024
Immatics to Raise $150M in Public Stock Offering
Mar 1, 2024
Feb 21, 2024
Feb 21, 2024